Cargando…
Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication
Increased expression of T cell immunoglobulin and mucin domain‐3 (Tim‐3) on invariant natural killer T (iNKT) cells is reported in chronic hepatitis B virus (HBV) infection. However, whether Tim‐3 regulates iNKT cells in chronic HBV condition remains unclear. In this study, our results showed that t...
Autores principales: | Xu, Yong, Wang, Zehua, Du, Xianhong, Liu, Yuan, Song, Xiaojia, Wang, Tixiao, Tan, Siyu, Liang, Xiaohong, Gao, Lifen, Ma, Chunhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5980221/ https://www.ncbi.nlm.nih.gov/pubmed/29602251 http://dx.doi.org/10.1111/jcmm.13600 |
Ejemplares similares
-
Exploring the Therapeutic Potentials of iNKT Cells for Anti-HBV Treatment
por: Lawrenczyk, Agnieszka, et al.
Publicado: (2014) -
Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway
por: Yang, Huimin, et al.
Publicado: (2019) -
iNKT and MAIT Cell Alterations in Diabetes
por: Magalhaes, Isabelle, et al.
Publicado: (2015) -
The Role of Autophagy in iNKT Cell Development
por: Yang, Guan, et al.
Publicado: (2018) -
Recent advances in iNKT cell development
por: Hogquist, Kristin, et al.
Publicado: (2020)